Important Safety Information Patient Information This website is intended for US residents only.
Sancuso Logo

SANCUSO® (granisetron transdermal system)
Patient Site Map

Indication and Important Safety Information For Patients

INDICATION

SANCUSO® (granisetron transdermal system) is indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration.

IMPORTANT SAFETY INFORMATION FOR PATIENTS

What is SANCUSO® (granisetron transdermal system)? 

SANCUSO is a prescription medicine used to prevent nausea and vomiting in patients receiving some types of chemotherapy treatment. SANCUSO is a skin patch that slowly releases the medicine contained in the adhesive (glue), through clean and intact skin areas into your bloodstream while you wear the patch. SANCUSO is for skin use only.

Who should not use SANCUSO?

Do not use SANCUSO if you are allergic to granisetron or any of the other ingredients in SANCUSO.

What should I tell my healthcare provider before using SANCUSO?

What should I avoid while using SANCUSO?

What are the possible side effects of SANCUSO?

The most common side effect of SANCUSO is constipation.

These are not all the possible side effects of SANCUSO. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

For more information, ask your healthcare provider or pharmacist.

To report suspected side effects, contact Kyowa Kirin, Inc. at 1-800-SANCUSO or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

See full Patient Information for SANCUSO.